awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34734477-01F029BF-7B39-4CA8-8D56-641F0332AE84
Q34734477-01F029BF-7B39-4CA8-8D56-641F0332AE84
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34734477-01F029BF-7B39-4CA8-8D56-641F0332AE84
Subtyping of triple-negative breast cancer: implications for therapy
P2860
Q34734477-01F029BF-7B39-4CA8-8D56-641F0332AE84
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34734477-01F029BF-7B39-4CA8-8D56-641F0332AE84
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5bd216bec39d657dd257a0b674427eb77b657306
P2860
Randomized phase II study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple-negative breast cancer.